GALMED PHARMACEUTICALS LTD. Common Stock, Value, Issued
GALMED PHARMACEUTICALS LTD. (GLMD) had Common Stock, Value, Issued of $4.26 million as of 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-09-02
- 2026-06-30: Common Stock, Value, Issued $4.26M.
- 2025-12-31: Common Stock, Value, Issued $3.41M.
- 2025-09-30: Common Stock, Value, Issued $2.79M.
- 2025-06-30: Common Stock, Value, Issued $2.69M.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $4.26M 6-K · filed 2026-09-02 |
| 2025-12-31 | $3.41M 6-K · filed 2026-09-02 |
| 2025-09-30 | $2.79M 6-K · filed 2025-11-26 |
| 2025-06-30 | $2.69M 6-K · filed 2025-08-28 |
| 2024-12-31 | $742.00K 20-F · filed 2026-03-31 |
| 2024-06-30 | $263.00K 6-K · filed 2024-08-28 |
| 2023-12-31 | $209.00K 20-F · filed 2025-04-02 |
| 2023-06-30 | $70.00K 6-K · filed 2023-08-09 |
| 2022-12-31 | $70.00K 20-F · filed 2024-04-04 |
| 2022-06-30 | $70.00K 6-K · filed 2022-08-04 |
| 2021-12-31 | $70.00K 20-F · filed 2023-03-29 |
| 2021-06-30 | $70.00K 6-K · filed 2021-08-05 |
| 2020-12-31 | $58.00K 20-F · filed 2022-05-02 |
| 2020-06-30 | $58.00K 6-K · filed 2020-08-06 |
| 2019-12-31 | $58.00K 20-F · filed 2021-03-18 |
| 2019-06-30 | $58.00K 6-K · filed 2019-08-05 |
| 2018-12-31 | $58.00K 20-F · filed 2020-03-12 |
| 2018-06-30 | $58.00K 6-K · filed 2018-08-02 |
| 2017-12-31 | $40.00K 20-F · filed 2019-03-13 |
| 2017-06-30 | $34.00K 6-K · filed 2017-07-31 |
| 2016-12-31 | $34.00K 20-F · filed 2018-03-13 |
| 2016-06-30 | $32.00K 6-K · filed 2017-06-23 |
| 2015-12-31 | $32.00K 6-K · filed 2017-06-23 |
| 2014-12-31 | $32.00K 20-F · filed 2016-03-22 |
| 2013-12-31 | $10.00K 20-F · filed 2015-03-31 |